Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Osorio, S; Casado, LF; Giraldo, P; Maestro, B; Andrade, M; Redondo, S; Garcia-Gutierrez, V; Ayala, R; Garcia, N; Steegmann, JL.

Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registry

REVISTA CLINICA ESPANOLA. 2016; 216(6): 293-300 Nº de citas: 5 [doi:10.1016/j.rce.2016.03.001]

Proserpio, T; Veneroni, L; Silva, M; Lassaletta, A; Lorenzo, R; Magni, C; Bertolotti, M; Barisone, E; Mascarin, M; Jankovic, M; D'Angelo, P; Clerici, CA; Garrido-Colino, C; Gutierrez-Carrasco, I; Echebarria, A; Biondi, A; Massimino, M; Casale, F; Tamburini, A; Ferrari, A.

Spiritual support for adolescent cancer patients: a survey of pediatric oncology centers in Italy and Spain

Tumori Journal. 2016; 102(4): 376-380 Nº de citas: 13 [doi:10.5301/tj.5000494]

De La Serna, J; Sanz, J; Bermudez, A; Cabrero, M; Serrano, D; Vallejo, C; Gomez, V; Moraleda, JM; Perez, SG; Caballero, MD; Conde, E; Lahuerta, JJ; Sanz, G.

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

BONE MARROW TRANSPLANTATION. 2016; 51(7): 961-966 Nº de citas: 13 [doi:10.1038/bmt.2016.42]

Bautista, F; Gallego, S; Canete, A; Mora, J; Heredia, CD; Cruz, O; Fernandez, JM; Rives, S; Madero, L; Castel, V; Cela, ME; Ramirez, G; Sabado, C; Acha, T; Astigarraga, I; Sastre, A; Munoz, A; Guibelalde, M; Moreno, L.

Landscape of early clinical trials for childhood and adolescence cancer in Spain

Clinical & Translational Oncology. 2016; 18(7): 708-713 Nº de citas: 6 [doi:10.1007/s12094-015-1421-9]

Paiva, B; Cedena, MT; Puig, N; Arana, P; Vidriales, MB; Cordon, L; Flores-Montero, J; Gutierrez, NC; Martin-Ramos, ML; Martinez-Lopez, J; Ocio, EM; Hernandez, MT; Teruel, AI; Rosinol, L; Echeveste, MA; Martinez, R; Gironella, M; Oriol, A; Cabrera, C; Martin, J; Bargay, J; Encinas, C; Gonzalez, Y; Van Dongen, JJM; Orfao, A; Blade, J; Mateos, MV; Lahuerta, JJ; San Miguel, JF.

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

BLOOD. 2016; 127(25): 3165-3174 Nº de citas: 137 [doi:10.1182/blood-2016-03-705319]

Castilla-Rodriguez, I; Cela, E; Vallejo-Torres, L; Valcarcel-Nazco, C; Dulin, E; Espada, M; Rausell, D; Mar, J; Serrano-Aguilar, P.

Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

Expert Opinion on Orphan Drugs. 2016; 4(6): 567-575 Nº de citas: 11 [doi:10.1080/21678707.2016.1179572]

Bastos-Oreiro, M; Anguita, J; Martinez-Laperche, C; Fernandez, L; Buces, E; Navarro, A; Pascual, C; Perez-Corral, A; Balsalobre, P; Munoz, C; Kwon, M; Serrano, D; Perez-Martinez, A; Buno, I; Gayoso, J; Diez-Martin, JL.

Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(5): 483-491 Nº de citas: 17 [doi:10.1111/ejh.12616]

Penalver, FJ; Delgado, J; Loscertales, J; Sastre, JL; Pena, A; Olave, MT; Osorio, S; de la Fuente, A; Salar, A; Grande, C; Ceballos, EP; Deben, G; Echeveste, A; Casado, F; de la Rubia, J; Lahuerta, JJ; Mateos, MV.

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(5): 532-540 Nº de citas: 2 [doi:10.1111/ejh.12633]

de la Fuente-Gonzalo, F; Nieto, JM; Velasco, D; Cela, E; Perez, G; Fernandez-Teijeiro, A; Escudero, A; Villegas, A; Gonzalez-Fernandez, FA; Ropero, P.

HB Puerta del Sol [HBA1: c. 148A > C], HB Valdecilla [HBA2: c. 3G > T], HB Gran Via [HBA2: c. 98T > G], HB Macarena [HBA2: c. 358C > T] and HB El Retiro [HBA2: c. 364_366dupGTG]: description of five new hemoglobinopathies

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2016; 54(4): 553-560 Nº de citas: 6 [doi:10.1515/cclm-2015-0649]

Yazer, MH; Lozano, M; Crighton, G; Greenway, A; Comande, M; Savoia, H; Wood, E; Gilli, S; Castilho, L; Saad, STO; Galacteros, F; Noizat-Pirenne, F; Pazgal, I; Stark, P; Orlin, Y; Perseghin, P; Masera, N; Cela, E; Anguita, J; Wikman, A; Delaney, M.

Transfusion service management of sickle-cell disease patients

VOX SANGUINIS. 2016; 110(3): 288 Nº de citas: 6 [doi:10.1111/vox.12296]

Martinez-Moreno, M; Leiva, M; Aguilera-Montilla, N; Sevilla-Movilla, S; de Val, SI; Arellano-Sanchez, N; Gutierrez, NC; Maldonado, R; Martinez-Lopez, J; Buno, I; Garcia-Marco, JA; Sanchez-Mateos, P; Hidalgo, A; Garcia-Pardo, A; Teixido, J.

In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by alpha 4 beta 1 cytoplasmic-binding proteins

LEUKEMIA. 2016; 30(4): 861-872 Nº de citas: 34 [doi:10.1038/leu.2015.332]

Forero-Castro, M; Robledo, C; Lumbreras, E; Benito, R; Hernandez-Sanchez, JM; Hernandez-Sanchez, M; Garcia, JL; Corchete-Sanchez, LA; Tormo, M; Barba, P; Menarguez, J; Ribera, J; Grande, C; Escoda, L; Olivier, C; Carrillo, E; de Coca, AG; Ribera, JM; Hernandez-Rivas, JM.

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab

BRITISH JOURNAL OF HAEMATOLOGY. 2016; 172(3): 428-438 Nº de citas: 22 [doi:10.1111/bjh.13849]

Escudero-Vilaplana, V; Garcia-Gonzalez, X; Osorio-Prendes, S; Romero-Jimenez, RM; Sanjurjo-Saez, M.

Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2016; 41(1): 59-63 Nº de citas: 8 [doi:10.1111/jcpt.12348]

Pinana, JL; Sanz, J; Esquirol, A; Martino, R; Picardi, A; Barba, P; Parody, R; Gayoso, J; Montesinos, P; Guidi, S; Terol, MJ; Moscardo, F; Solano, C; Arcese, W; Sanz, MA; Sierra, J; Sanz, G.

Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(2): 128-135 Nº de citas: 14 [doi:10.1111/ejh.12557]

Mateos, MV; Martinez-Lopez, J; Hernandez, MT; Ocio, EM; Rosinol, L; Martinez, R; Teruel, AI; Gutierrez, NC; Ramos, MLM; Oriol, A; Bargay, J; Bengoechea, E; Gonzalez, Y; de Oteyza, JP; Gironella, M; Encinas, C; Martin, J; Cabrera, C; Paiva, B; Cedena, MT; Puig, N; Blade, J; Lahuerta, JJ; San-Miguel, J.

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM

BLOOD. 2016; 127(4): 420-425 Nº de citas: 54 [doi:10.1182/blood-2015-08-666537]

Kelleher, N; Garcia, O; Gallardo, D; Gonzalez-Campos, J; Hernandez-Rivas, JM; Montesinos, P; Sarra, J; Gil, C; Barba, P; Guardia, R; Brunet, S; Bernal, T; Martinez, MP; Abella, E; Bermudez, A; Sanchez-Delgado, M; Antonia, C; Gayoso, J; Calbacho, M; Ribera, JM.

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

LEUKEMIA & LYMPHOMA. 2016; 57(1): 86-91 Nº de citas: 17 [doi:10.3109/10428194.2015.1040013]

Medin, G; Garcia-Navarro, C; Gomez, MN; Amador, JTR; Mellado, MJ; Jimenez, S; Munoz-Fernandez, MA; Conejo, PR; Saavedra, J; Hortelano, MG; Guillen, S; Gonzalez-Tome, MI.

Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 2016; 28(1): 124-130 Nº de citas: 19 [doi:10.1080/09540121.2015.1071768]

Perez-Chacon, G; Martinez-Laperche, C; Rebolleda, N; Somovilla-Crespo, B; Munoz-Calleja, C; Buno, I; Zapata, JM.

Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances

CLINICAL CANCER RESEARCH. 2016; 22(1): 134-145 Nº de citas: 10 [doi:10.1158/1078-0432.CCR-15-0736]